U.S. flag

An official website of the United States government

NM_052989.3(IFT122):c.3426_3430del (p.Ser1143fs) AND Cranioectodermal dysplasia 1

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 7, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001783467.5

Allele description [Variation Report for NM_052989.3(IFT122):c.3426_3430del (p.Ser1143fs)]

NM_052989.3(IFT122):c.3426_3430del (p.Ser1143fs)

Gene:
IFT122:intraflagellar transport 122 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3q22.1
Genomic location:
Preferred name:
NM_052989.3(IFT122):c.3426_3430del (p.Ser1143fs)
HGVS:
  • NC_000003.12:g.129519141_129519145del
  • NG_023392.1:g.84017_84021del
  • NM_001280541.2:c.3405_3409del
  • NM_001280545.2:c.2976_2980del
  • NM_001280546.2:c.2799_2803del
  • NM_018262.4:c.3249_3253del
  • NM_052985.4:c.3579_3583del
  • NM_052989.3:c.3426_3430delMANE SELECT
  • NM_052990.3:c.3096_3100del
  • NP_001267470.1:p.Ser1136fs
  • NP_001267474.1:p.Ser993fs
  • NP_001267475.1:p.Ser934fs
  • NP_060732.2:p.Ser1084fs
  • NP_443711.2:p.Ser1194fs
  • NP_443715.1:p.Ser1143fs
  • NP_443716.1:p.Ser1033fs
  • NC_000003.11:g.129237983_129237987del
  • NC_000003.11:g.129237984_129237988del
  • NM_052985.3:c.3579_3583del
Protein change:
S1033fs
Links:
dbSNP: rs1299632365
NCBI 1000 Genomes Browser:
rs1299632365
Molecular consequence:
  • NM_001280541.2:c.3405_3409del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001280545.2:c.2976_2980del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001280546.2:c.2799_2803del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_018262.4:c.3249_3253del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_052985.4:c.3579_3583del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_052989.3:c.3426_3430del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_052990.3:c.3096_3100del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Cranioectodermal dysplasia 1 (CED1)
Synonyms:
LEVIN SYNDROME I; Levin syndrome 1
Identifiers:
MONDO: MONDO:0021093; MedGen: C0432235; Orphanet: 1515; OMIM: 218330

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002023129Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 13, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV003255668Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 7, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Cranioectodermal Dysplasia, Sensenbrenner syndrome, is a ciliopathy caused by mutations in the IFT122 gene.

Walczak-Sztulpa J, Eggenschwiler J, Osborn D, Brown DA, Emma F, Klingenberg C, Hennekam RC, Torre G, Garshasbi M, Tzschach A, Szczepanska M, Krawczynski M, Zachwieja J, Zwolinska D, Beales PL, Ropers HH, Latos-Bielenska A, Kuss AW.

Am J Hum Genet. 2010 Jun 11;86(6):949-56. doi: 10.1016/j.ajhg.2010.04.012. Epub 2010 May 20.

PubMed [citation]
PMID:
20493458
PMCID:
PMC3032067
See all PubMed Citations (5)

Details of each submission

From Revvity Omics, Revvity, SCV002023129.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV003255668.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Ser1194Argfs*3) in the IFT122 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT122 are known to be pathogenic (PMID: 20493458, 23826986, 26792575). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with IFT122-related conditions. ClinVar contains an entry for this variant (Variation ID: 1323103). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024